EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

20.40p
   
  • Change Today:
    -1.00p
  • 52 Week High: 33.20
  • 52 Week Low: 18.75
  • Currency: UK Pounds
  • Shares Issued: 454.93m
  • Volume: 1,011,928
  • Market Cap: £92.81m

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: Gavin T Jones
CFO: Stephen (Steve) Young
Executive Chairman: Julian Baines
Senior Independent Director: Christian Alexander Rigg
Non-Executive Dir: Jenny Winter, Christopher H B Mills

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 20.40p
Change Today -1.00p
% Change -4.67 %
52 Week High 33.20
52 Week Low 18.75
Volume 1,011,928
Shares Issued 454.93m
Market Cap £92.81m

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
75.53% below the market average75.53% below the market average75.53% below the market average75.53% below the market average75.53% below the market average
72% below the sector average72% below the sector average72% below the sector average72% below the sector average72% below the sector average
Price Trend
56.85% below the market average56.85% below the market average56.85% below the market average56.85% below the market average56.85% below the market average
62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average
Income Not Available
Growth
57.71% above the market average57.71% above the market average57.71% above the market average57.71% above the market average57.71% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 12-May-2025

Time Volume / Share Price
09:29 209,000 @ 20.48p
08:39 258,775 @ 21.50p
16:35 3,166 @ 20.40p
16:35 833 @ 20.40p
16:35 439 @ 20.40p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page